Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy

TUESDAY, April 20, 2021 -- Cutaneous immune-related adverse events (irAEs) are associated with initiation of immune checkpoint inhibitor (ICI) treatment in cancer patients, according to a study published online April 12 in the Journal of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news